NCT04198766 2025-12-18Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Inhibrx Biosciences, IncPhase 1/2 Active not recruiting296 enrolled
NCT00006036 2020-04-06Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsCanadian Cancer Trials GroupPhase 1 Completed14 enrolled
NCT00703638 2017-11-29Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid TumorsMasonic Cancer Center, University of MinnesotaPhase 1 Completed16 enrolled
NCT00003569 2013-01-31Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and PaclitaxelRoswell Park Cancer InstituteCompleted2 enrolled